Charles River Laboratories International Quarterly Income Statements Chart
Quarterly
|
Annual
Charles River Laboratories International Quarterly Income Statements Table
Quarterly
|
Annual
Unit: USD | 2025-06-28 | 2025-03-29 | 2024-12-28 | 2024-09-28 | 2024-06-29 | 2024-03-30 | 2023-12-30 | 2023-09-30 | 2023-07-01 | 2023-04-01 | 2022-12-31 | 2022-09-24 | 2022-06-25 | 2022-03-26 | 2021-12-25 | 2021-09-25 | 2021-06-26 | 2021-03-27 | 2020-12-26 | 2020-09-26 | 2020-06-27 | 2020-03-28 | 2019-12-28 | 2019-09-28 | 2019-06-29 | 2019-03-30 | 2018-12-29 | 2018-09-29 | 2018-06-30 | 2018-03-31 | 2017-12-30 | 2017-09-30 | 2017-07-01 | 2017-04-01 | 2016-12-31 | 2016-09-24 | 2016-06-25 | 2016-03-26 | 2015-12-26 | 2015-09-26 | 2015-06-27 | 2015-03-28 | 2014-12-27 | 2014-09-27 | 2014-06-28 | 2014-03-29 | 2013-12-28 | 2013-09-28 | 2013-06-29 | 2013-03-30 | 2012-12-29 | 2012-09-29 | 2012-06-30 | 2012-03-31 | 2011-12-31 | 2007-06-30 | 2007-03-31 | 2006-12-30 | 2006-09-30 | 2006-07-01 | 2006-04-01 | 2005-12-31 | 2005-09-24 | 2005-06-25 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
service revenue | 840,836,000 | 797,923,000 | 811,913,000 | 832,463,000 | 842,900,000 | 816,862,000 | 838,003,000 | 869,759,000 | 874,891,000 | 857,366,000 | 900,698,000 | 812,894,000 | 782,827,000 | 720,485,000 | 709,819,000 | 703,859,000 | 715,320,000 | 626,581,000 | 618,229,000 | 580,774,000 | 550,561,000 | 546,592,000 | 549,380,000 | 523,169,000 | 505,880,000 | 450,942,000 | 460,993,000 | 443,038,000 | 438,456,000 | 345,454,000 | 337,658,000 | 326,711,000 | 329,398,000 | 304,531,000 | 324,336,000 | 292,849,000 | 292,847,000 | 220,701,000 | 224,578,000 | 222,506,000 | 214,380,000 | 196,780,000 | 209,666,000 | 204,751,000 | 211,003,000 | 172,345,000 | ||||||||||||||||||
product revenue | 191,299,000 | 186,245,000 | 190,636,000 | 177,300,000 | 183,217,000 | 194,698,000 | 175,473,000 | 156,864,000 | 185,046,000 | 172,007,000 | 199,145,000 | 176,263,000 | 190,304,000 | 193,444,000 | 195,231,000 | 192,078,000 | 199,287,000 | 197,985,000 | 172,761,000 | 162,526,000 | 132,023,000 | 160,467,000 | 141,758,000 | 144,782,000 | 151,688,000 | 153,627,000 | 140,537,000 | 142,257,000 | 146,845,000 | 148,516,000 | 140,819,000 | 137,521,000 | 139,731,000 | 141,232,000 | 142,453,000 | 132,871,000 | 141,208,000 | 134,167,000 | 129,272,000 | 126,959,000 | 125,193,000 | 123,634,000 | 119,882,000 | 122,816,000 | 130,176,000 | 127,023,000 | ||||||||||||||||||
total revenue | 1,032,135,000 | 984,168,000 | 1,002,549,000 | 1,009,763,000 | 1,026,117,000 | 1,011,560,000 | 1,013,476,000 | 1,026,623,000 | 1,059,937,000 | 1,029,373,000 | 1,099,843,000 | 989,157,000 | 973,131,000 | 913,929,000 | 905,050,000 | 895,937,000 | 914,607,000 | 824,566,000 | 790,990,000 | 743,300,000 | 682,584,000 | 707,059,000 | 691,138,000 | 667,951,000 | 657,568,000 | 604,569,000 | 601,530,000 | 585,295,000 | 585,301,000 | 493,970,000 | 478,477,000 | 464,232,000 | 469,129,000 | 445,763,000 | 466,789,000 | 425,720,000 | 434,055,000 | 354,868,000 | 353,850,000 | 349,465,000 | 339,573,000 | 320,414,000 | 329,548,000 | 327,567,000 | 341,179,000 | 299,368,000 | ||||||||||||||||||
yoy | 0.59% | -2.71% | -1.08% | -1.64% | -3.19% | -1.73% | -7.85% | 3.79% | 8.92% | 12.63% | 21.52% | 10.40% | 6.40% | 10.84% | 14.42% | 20.54% | 33.99% | 16.62% | 14.45% | 11.28% | 3.80% | 16.95% | 14.90% | 14.12% | 12.35% | 22.39% | 25.72% | 26.08% | 24.76% | 10.81% | 2.50% | 9.05% | 8.08% | 25.61% | 31.92% | 21.82% | 27.82% | 10.75% | 7.37% | 6.69% | -0.47% | 7.03% | ||||||||||||||||||||||
qoq | 4.87% | -1.83% | -0.71% | -1.59% | 1.44% | -0.19% | -1.28% | -3.14% | 2.97% | -6.41% | 11.19% | 1.65% | 6.48% | 0.98% | 1.02% | -2.04% | 10.92% | 4.24% | 6.42% | 8.90% | -3.46% | 2.30% | 3.47% | 1.58% | 8.77% | 0.51% | 2.77% | -0.00% | 18.49% | 3.24% | 3.07% | -1.04% | 5.24% | -4.50% | 9.65% | -1.92% | 22.31% | 0.29% | 1.25% | 2.91% | 5.98% | -2.77% | 0.60% | -3.99% | 13.97% | |||||||||||||||||||
costs and expenses | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cost of services provided | 584,876,000 | 577,428,000 | 621,535,000 | 568,699,000 | 577,383,000 | 578,164,000 | 564,847,000 | 587,560,000 | 578,099,000 | 565,477,000 | 603,125,000 | 530,706,000 | 522,623,000 | 486,864,000 | 468,091,000 | 468,659,000 | 476,762,000 | 423,975,000 | 408,242,000 | 377,226,000 | 374,938,000 | 372,824,000 | 357,636,000 | 351,894,000 | 345,369,000 | 316,800,000 | 306,241,000 | 298,018,000 | 302,304,000 | 243,808,000 | 224,714,000 | 219,368,000 | 214,716,000 | 206,820,000 | 214,144,000 | 200,118,000 | 196,121,000 | 147,349,000 | 142,613,000 | 145,165,000 | 144,143,000 | 136,306,000 | 142,602,000 | 144,053,000 | 147,954,000 | 123,969,000 | 127,483,000 | 121,909,000 | 123,736,000 | 120,994,000 | 120,787,000 | 121,778,000 | 119,103,000 | 116,824,000 | 125,790,000 | 119,492,000 | 109,865,000 | 107,338,000 | 129,798,000 | 119,768,000 | 120,551,000 | |||
cost of products sold | 90,192,000 | 89,008,000 | 96,770,000 | 92,043,000 | 95,021,000 | 88,553,000 | 84,544,000 | 77,223,000 | 82,861,000 | 86,242,000 | 97,834,000 | 88,228,000 | 93,782,000 | 90,247,000 | 89,847,000 | 90,051,000 | 95,824,000 | 92,313,000 | 82,780,000 | 76,800,000 | 75,408,000 | 82,174,000 | 71,188,000 | 69,941,000 | 74,095,000 | 75,992,000 | 68,872,000 | 71,077,000 | 67,016,000 | 68,693,000 | 86,014,000 | 67,660,000 | 68,751,000 | 67,244,000 | 72,764,000 | 69,332,000 | 68,187,000 | 66,751,000 | 70,663,000 | 66,225,000 | 62,647,000 | 64,448,000 | 67,001,000 | 65,246,000 | 67,591,000 | 66,586,000 | 69,348,000 | 70,294,000 | 66,627,000 | 66,033,000 | 64,780,000 | 63,649,000 | 62,035,000 | 64,945,000 | 60,689,000 | 56,134,000 | 52,533,000 | 53,411,000 | 50,787,000 | 47,377,000 | 51,076,000 | |||
selling, general and administrative | 191,549,000 | 177,799,000 | 195,708,000 | 199,213,000 | 169,791,000 | 186,291,000 | 197,142,000 | 176,109,000 | 199,758,000 | 174,846,000 | 199,640,000 | 183,714,000 | 131,711,000 | 150,033,000 | 144,112,000 | 148,573,000 | 171,501,000 | 155,733,000 | 143,033,000 | 128,289,000 | 127,712,000 | 129,901,000 | 129,598,000 | 129,509,000 | 135,941,000 | 122,574,000 | 106,918,000 | 113,033,000 | 120,531,000 | 103,372,000 | 94,560,000 | 92,863,000 | 94,533,000 | 91,490,000 | 98,481,000 | 85,650,000 | 100,473,000 | 82,944,000 | 81,461,000 | 76,225,000 | 71,331,000 | 71,397,000 | 72,034,000 | 64,476,000 | 67,756,000 | 64,767,000 | 58,674,000 | 54,903,000 | 54,919,000 | 57,199,000 | 51,324,000 | 51,047,000 | 49,900,000 | 55,977,000 | 56,092,000 | 53,017,000 | 41,211,000 | 50,031,000 | 47,772,000 | 42,978,000 | 47,615,000 | |||
amortization of intangible assets | 65,384,000 | 65,264,000 | 41,223,000 | 32,403,000 | 32,270,000 | 32,575,000 | 34,021,000 | 34,229,000 | 34,274,000 | 34,916,000 | 35,434,000 | 35,533,000 | 37,604,000 | 38,007,000 | 30,193,000 | 32,852,000 | 32,970,000 | 28,842,000 | 28,008,000 | 28,232,000 | 27,758,000 | 27,879,000 | 23,927,000 | 23,805,000 | 22,395,000 | 19,411,000 | 17,017,000 | 18,805,000 | 18,740,000 | 10,268,000 | 10,457,000 | 10,357,000 | 9,819,000 | 10,737,000 | 12,309,000 | 11,825,000 | 11,213,000 | 6,352,000 | 6,844,000 | 6,410,000 | 5,717,000 | 5,258,000 | 7,144,000 | 7,620,000 | ||||||||||||||||||||
operating income | 100,134,000 | 74,669,000 | -167,687,000 | 117,405,000 | 151,652,000 | 125,977,000 | 132,922,000 | 151,502,000 | 164,945,000 | 167,892,000 | 163,810,000 | 150,976,000 | 187,411,000 | 148,778,000 | 172,807,000 | 155,802,000 | 137,550,000 | 123,703,000 | 128,927,000 | 132,753,000 | 76,768,000 | 94,281,000 | 108,789,000 | 92,802,000 | 79,768,000 | 69,792,000 | 102,482,000 | 84,362,000 | 76,710,000 | 67,829,000 | 62,732,000 | 73,984,000 | 81,310,000 | 69,472,000 | 69,091,000 | 58,795,000 | 58,061,000 | 51,472,000 | 52,269,000 | 55,440,000 | 55,735,000 | 43,005,000 | 40,767,000 | 46,172,000 | 51,025,000 | 39,706,000 | 24,607,000 | 40,843,000 | 43,188,000 | 42,763,000 | 35,069,000 | 37,682,000 | 49,274,000 | 43,740,000 | 56,725,000 | 54,701,000 | 51,621,000 | 47,702,000 | 49,494,000 | 49,853,000 | ||||
yoy | -33.97% | -40.73% | -226.15% | -22.51% | -8.06% | -24.97% | -18.86% | 0.35% | -11.99% | 12.85% | -5.21% | -3.10% | 36.25% | 20.27% | 34.03% | 17.36% | 79.18% | 31.21% | 18.51% | 43.05% | -3.76% | 35.09% | 6.15% | 10.00% | 3.99% | 2.89% | 63.36% | 14.03% | -5.66% | -2.36% | -9.20% | 25.83% | 40.04% | 34.97% | 32.18% | 6.05% | 4.17% | 19.69% | 28.21% | 20.07% | 9.23% | 8.31% | 65.67% | 13.05% | 18.15% | -7.15% | -29.83% | 8.39% | -12.35% | -2.23% | -33.57% | -9.92% | 18.92% | 4.30% | -4.31% | |||||||||
qoq | 34.10% | -144.53% | -242.83% | -22.58% | 20.38% | -5.22% | -12.26% | -8.15% | -1.76% | 2.49% | 8.50% | -19.44% | 25.97% | -13.91% | 10.91% | 13.27% | 11.19% | -4.05% | -2.88% | 72.93% | -18.58% | -13.34% | 17.23% | 16.34% | 14.29% | -31.90% | 21.48% | 9.98% | 13.09% | 8.13% | -15.21% | -9.01% | 17.04% | 0.55% | 17.51% | 1.26% | 12.80% | -1.52% | -5.72% | -0.53% | 29.60% | 5.49% | -11.71% | -9.51% | 28.51% | 61.36% | -39.75% | -5.43% | 0.99% | 21.94% | -6.93% | -23.53% | 12.65% | 3.70% | 8.22% | -0.72% | ||||||||
operating margin % | 9.70% | 7.59% | -16.73% | 11.63% | 14.78% | 12.45% | 13.12% | 14.76% | 15.56% | 16.31% | 14.89% | 15.26% | 19.26% | 16.28% | 19.09% | 17.39% | 15.04% | 15.00% | 16.30% | 17.86% | 11.25% | 13.33% | 15.74% | 13.89% | 12.13% | 11.54% | 17.04% | 14.41% | 13.11% | 13.73% | 13.11% | 15.94% | 17.33% | 15.58% | 14.80% | 13.81% | 13.38% | 14.50% | 14.77% | 15.86% | 16.41% | 13.42% | 12.37% | 14.10% | 14.96% | 13.26% | ||||||||||||||||||
other income | 154,000 | -12,211,000 | -22,705,000 | 2,592,000 | -2,240,000 | 5,833,000 | 107,737,000 | -6,260,000 | -2,663,000 | -3,277,000 | 115,547,000 | -16,616,000 | -39,783,000 | -28,625,000 | 2,072,000 | -16,214,000 | 5,965,000 | -27,717,000 | 76,584,000 | 21,211,000 | 26,260,000 | -24,071,000 | 20,454,000 | -14,254,000 | -213,000 | 6,306,000 | -10,811,000 | 5,910,000 | 12,039,000 | 6,120,000 | 13,852,000 | 6,488,000 | 2,848,000 | 15,356,000 | 1,838,000 | 1,017,000 | 5,016,000 | 4,026,000 | 1,259,000 | 1,390,000 | 8,672,000 | -8,313,000 | 1,847,000 | 331,000 | 2,667,000 | 5,876,000 | 1,523,500 | 4,059,000 | ||||||||||||||||
interest income | 1,097,000 | 1,404,000 | 1,835,000 | 1,528,000 | 3,010,000 | 2,202,000 | 1,591,000 | 1,373,000 | 1,426,000 | 806,000 | 343,000 | 122,000 | 188,000 | 127,000 | 309,000 | 137,000 | 171,000 | 35,000 | 63,000 | 179,000 | 276,000 | 316,000 | 684,000 | 385,000 | 274,000 | 179,000 | 118,000 | 230,000 | 182,000 | 282,000 | 193,000 | 134,000 | 161,000 | 202,000 | 306,000 | 523,000 | 222,000 | 263,000 | 285,000 | 177,000 | 297,000 | 284,000 | 351,000 | 376,000 | 222,000 | 205,000 | 254,000 | 143,000 | 236,000 | 97,000 | 129,000 | 124,000 | 151,000 | 185,000 | 2,304,000 | 2,287,000 | 2,503,000 | 957,000 | 852,000 | 982,000 | 943,000 | |||
interest expense | -29,967,000 | -27,884,000 | -28,234,000 | -30,284,000 | -32,769,000 | -35,001,000 | -33,544,000 | -33,742,000 | -35,044,000 | -34,380,000 | -34,779,000 | -11,375,000 | -3,703,000 | -9,434,000 | -11,546,000 | -16,455,000 | -16,190,000 | -29,719,000 | -33,147,000 | -18,867,000 | -19,352,000 | -15,067,000 | -24,362,000 | -5,698,000 | -20,835,000 | -9,987,000 | -16,741,000 | -17,197,000 | -18,643,000 | -11,191,000 | -7,724,000 | -7,667,000 | -7,403,000 | -6,983,000 | -7,510,000 | -7,079,000 | -8,909,000 | -4,211,000 | -3,821,000 | -3,851,000 | -4,376,000 | -3,024,000 | -2,779,000 | -2,997,000 | -3,373,000 | -2,801,000 | -2,826,000 | -2,319,000 | -7,544,000 | -8,280,000 | -8,309,000 | -8,519,000 | -8,079,000 | -8,435,000 | -6,107,000 | -4,784,000 | ||||||||
income before income taxes | 71,418,000 | 35,978,000 | -216,791,000 | 91,241,000 | 119,653,000 | 99,011,000 | 208,706,000 | 112,873,000 | 128,664,000 | 131,041,000 | 244,921,000 | 123,107,000 | 144,113,000 | 110,846,000 | 163,642,000 | 123,270,000 | 127,496,000 | |||||||||||||||||||||||||||||||||||||||||||||||
benefit from income taxes | 18,725,000 | 10,100,000 | -3,044,000 | 20,946,000 | 25,392,000 | 24,529,000 | 19,754,000 | 24,852,000 | 29,221,000 | 27,087,000 | 55,815,000 | 25,495,000 | 33,449,000 | 15,620,000 | 23,815,000 | 18,111,000 | 37,580,000 | 2,367,000 | 16,284,000 | 4,622,000 | 14,685,000 | 10,602,000 | 14,850,000 | 12,403,000 | 17,438,000 | 9,772,000 | 98,097,000 | 19,945,000 | 22,243,000 | 31,084,000 | 18,450,000 | 15,565,000 | 18,845,000 | 13,975,000 | 16,729,000 | 15,255,000 | 11,076,000 | 331,000 | 11,650,000 | 11,582,000 | 14,081,000 | 10,358,000 | 3,580,000 | 11,390,000 | 8,219,000 | 9,722,000 | 3,488,000 | 6,011,000 | 15,101,000 | 15,310,000 | 15,489,000 | 9,870,000 | 12,039,000 | 12,588,000 | 12,460,000 | |||||||||
net income | 52,693,000 | 25,878,000 | -213,747,000 | 70,295,000 | 94,261,000 | 74,482,000 | 188,952,000 | 88,021,000 | 99,443,000 | 103,954,000 | 189,106,000 | 97,612,000 | 110,664,000 | 95,226,000 | 139,827,000 | 105,159,000 | 89,916,000 | 63,935,000 | 144,190,000 | 102,611,000 | 67,668,000 | 50,837,000 | 80,512,000 | 73,552,000 | 44,309,000 | 55,688,000 | 60,198,000 | 60,902,000 | 54,379,000 | 53,245,000 | -29,067,000 | 52,955,000 | 54,602,000 | 46,959,000 | 45,227,000 | 38,033,000 | 35,557,000 | 37,549,000 | 32,361,000 | 37,867,000 | 49,245,000 | 31,614,000 | 27,672,000 | 32,352,000 | 35,816,000 | 32,358,000 | 19,444,000 | 31,223,000 | 27,713,000 | 25,771,000 | 18,528,000 | 22,202,000 | 30,589,000 | 26,547,000 | 37,956,000 | 36,763,000 | -16,606,000 | 25,749,000 | -100,115,000 | 32,073,000 | 31,860,000 | |||
yoy | -44.10% | -65.26% | -213.12% | -20.14% | -5.21% | -28.35% | -0.08% | -9.83% | -10.14% | 9.17% | 35.24% | -7.18% | 23.07% | 48.94% | -3.03% | 2.48% | 32.88% | 25.76% | 79.09% | 39.51% | 52.72% | -8.71% | 33.75% | 20.77% | -18.52% | 4.59% | -307.10% | 15.01% | -0.41% | 13.39% | -164.27% | 39.23% | 53.56% | 25.06% | 39.76% | 0.44% | -27.80% | 18.77% | 16.94% | 17.05% | 37.49% | -2.30% | 42.32% | 3.62% | 29.24% | 25.56% | 4.94% | 40.63% | -9.40% | -2.92% | -41.51% | -16.79% | 47.41% | -136.72% | -151.78% | -19.18% | ||||||||
qoq | 103.62% | -112.11% | -404.07% | -25.43% | 26.56% | -60.58% | 114.67% | -11.49% | -4.34% | -45.03% | 93.73% | -11.79% | 16.21% | -31.90% | 32.97% | 16.95% | 40.64% | -55.66% | 40.52% | 51.64% | 33.11% | -36.86% | 9.46% | 66.00% | -20.43% | -7.49% | -1.16% | 12.00% | 2.13% | -283.18% | -154.89% | -3.02% | 16.28% | 3.83% | 18.92% | 6.96% | -5.31% | 16.03% | -14.54% | -23.10% | 55.77% | 14.25% | -14.47% | -9.67% | 10.69% | 66.42% | -37.73% | 12.67% | 7.54% | 39.09% | -16.55% | -27.42% | 15.23% | 3.25% | -164.49% | -125.72% | 0.67% | |||||||
net income margin % | 5.11% | 2.63% | -21.32% | 6.96% | 9.19% | 7.36% | 18.64% | 8.57% | 9.38% | 10.10% | 17.19% | 9.87% | 11.37% | 10.42% | 15.45% | 11.74% | 9.83% | 7.75% | 18.23% | 13.80% | 9.91% | 7.19% | 11.65% | 11.01% | 6.74% | 9.21% | 10.01% | 10.41% | 9.29% | 10.78% | -6.07% | 11.41% | 11.64% | 10.53% | 9.69% | 8.93% | 8.19% | 10.58% | 9.15% | 10.84% | 14.50% | 9.87% | 8.40% | 9.88% | 10.50% | 10.81% | ||||||||||||||||||
less: net income attributable to noncontrolling interests | 367,000 | 409,000 | 748,000 | 638,000 | 180,000 | 1,522,000 | 1,868,000 | 632,000 | 2,423,000 | 823,000 | 1,696,000 | 1,139,000 | 1,343,000 | 2,204,000 | 2,249,000 | 1,733,000 | 1,468,000 | 2,405,000 | 999,000 | -298,000 | 233,000 | 68,000 | 164,000 | 742,000 | 581,000 | 555,000 | 533,000 | 534,000 | 670,000 | 614,000 | 782,000 | 481,000 | 650,000 | 181,000 | 547,000 | 298,000 | 350,000 | -406,000 | -477,000 | -488,000 | -736,000 | -73,000 | -506,000 | -316,000 | -552,000 | -126,000 | -244,500 | -356,000 | -429,000 | -193,000 | -114,750 | -230,000 | -121,000 | -108,000 | ||||||||||
net income attributable to charles river laboratories international, inc. | 52,326,000 | 25,469,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
calculation of net income per share attributable to charles river laboratories international, inc. common shareholders | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: adjustment of redeemable noncontrolling interests | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: incremental dividends attributed to noncontrolling interest holders | 2,285 | 599 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income available to charles river laboratories international, inc. common shareholders | 52,326 | 25,469 | 89,988 | 67,329 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings per common share | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | 1.06 | 0.5 | -4.19 | 1.34 | -1,400 | 450 | 460 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
diluted | 1.06 | 0.5 | -4.17 | 1.33 | -1,400 | 440 | 440 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
weighted-average number of common shares outstanding | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | 49,149 | 50,677 | 51,380 | 51,394 | 51,551 | 51,437 | 51,227,000 | 51,283,000 | 51,216,000 | 51,097,000 | 50,812,000 | 50,870,000 | 50,823,000 | 50,640,000 | 50,293,000 | 50,425,000 | 50,297,000 | 49,980,000 | 49,550,000 | 49,703,000 | 49,553,000 | 49,189,000 | 48,730,000 | 48,818,000 | 48,772,000 | 48,458,000 | 47,947,000 | |||||||||||||||||||||||||||||||||||||
diluted | 49,316 | 50,853 | 51,628 | 51,583 | 51,846 | 51,842 | 51,451,000 | 51,607,000 | 51,467,000 | 51,428,000 | 51,301,000 | 51,283,000 | 51,283,000 | 51,325,000 | 51,425,000 | 51,558,000 | 51,334,000 | 51,075,000 | 50,611,000 | 50,702,000 | 50,246,000 | 49,966,000 | 49,693,000 | 49,715,000 | 49,662,000 | 49,462,000 | 49,018,000 | |||||||||||||||||||||||||||||||||||||
see notes to unaudited condensed consolidated financial statements. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income attributable to charles river laboratories international inc. | -214,495,000 | 69,657,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
calculation of net income per share attributable to charles river laboratories international inc. common shareholders | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: adjustment of redeemable noncontrolling interest | 270.25 | 379 | 301 | 401 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income available to charles river laboratories international inc. common shareholders | -215,699 | 68,679 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
costs and expenses: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other income: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income available to charles river laboratories international, inc. | 94,081,000 | 72,960,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
calculation of net income per share attributable to common shareholders of charles river laboratories international, inc. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: incremental dividends attributable to noncontrolling interest holders | 3,792 | 5,230 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings per common share | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income attributable to common shareholders: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | 1.75 | 1.31 | 3,650 | 1,700 | 1,890 | 2,020 | 3,690 | 1,900 | 2,150 | 1,840 | 2,730 | 2,050 | 1,760 | 1,230 | 1,117.5 | 2,070 | 1,360 | 1,030 | ||||||||||||||||||||||||||||||||||||||||||||||
diluted | 1.74 | 1.3 | 3,640 | 1,690 | 1,890 | 2,010 | 3,650 | 1,880 | 2,130 | 1,810 | 2,670 | 2,010 | 1,720 | 1,200 | 1,097.5 | 2,030 | 1,340 | 1,020 | ||||||||||||||||||||||||||||||||||||||||||||||
weighted-average number of common shares outstanding: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | 49,149 | 50,677 | 51,380 | 51,394 | 51,551 | 51,437 | 51,227,000 | 51,283,000 | 51,216,000 | 51,097,000 | 50,812,000 | 50,870,000 | 50,823,000 | 50,640,000 | 50,293,000 | 50,425,000 | 50,297,000 | 49,980,000 | 49,550,000 | 49,703,000 | 49,553,000 | 49,189,000 | 48,730,000 | 48,818,000 | 48,772,000 | 48,458,000 | 47,947,000 | |||||||||||||||||||||||||||||||||||||
diluted | 49,316 | 50,853 | 51,628 | 51,583 | 51,846 | 51,842 | 51,451,000 | 51,607,000 | 51,467,000 | 51,428,000 | 51,301,000 | 51,283,000 | 51,283,000 | 51,325,000 | 51,425,000 | 51,558,000 | 51,334,000 | 51,075,000 | 50,611,000 | 50,702,000 | 50,246,000 | 49,966,000 | 49,693,000 | 49,715,000 | 49,662,000 | 49,462,000 | 49,018,000 | |||||||||||||||||||||||||||||||||||||
net income attributable to common shareholders | 187,084,000 | 87,389,000 | 97,020,000 | 103,131,000 | 187,410,000 | 96,473,000 | 109,321,000 | 93,022,000 | 137,578,000 | 103,426,000 | 88,448,000 | 61,530,000 | 143,191,000 | 102,909,000 | 67,435,000 | 50,769,000 | 80,348,000 | 72,810,000 | 43,728,000 | 55,133,000 | 59,665,000 | 60,368,000 | 53,709,000 | 52,631,000 | -29,849,000 | 52,474,000 | 53,952,000 | 46,778,000 | 44,680,000 | 37,735,000 | 35,207,000 | 37,143,000 | 31,884,000 | 37,379,000 | 48,509,000 | 31,541,000 | 27,166,000 | 32,036,000 | 35,264,000 | 32,232,000 | 19,099,000 | 30,867,000 | 27,284,000 | |||||||||||||||||||||
income from operations, before income taxes | 66,302,000 | 68,671,750 | 135,276,000 | 83,952,000 | 55,459,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
benefit for income taxes | 13,392,750 | 32,665,000 | 6,242,500 | -317,000 | 9,453,000 | 8,676,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from continuing operations, before income taxes | 105,565,000 | 73,235,000 | 58,994,000 | 66,290,000 | 75,048,000 | 73,305,000 | 70,288,000 | 63,040,000 | 69,053,000 | 72,939,000 | 76,916,000 | 78,047,000 | 63,725,000 | 53,256,000 | 54,390,000 | 51,550,000 | 49,992,000 | 53,156,000 | 60,328,000 | 31,952,000 | 40,186,000 | 43,882,000 | 50,541,000 | 42,986,000 | 23,106,000 | 42,726,000 | 36,847,000 | 35,648,000 | 26,205,000 | 28,395,000 | 40,000,000 | 35,146,000 | ||||||||||||||||||||||||||||||||
income from continuing operations, net of income taxes | 80,512,000 | 73,552,000 | 44,309,000 | 55,688,000 | 60,198,000 | 60,902,000 | 52,850,000 | 53,268,000 | -29,044,000 | 52,994,000 | 54,673,000 | 46,963,000 | 45,275,000 | 37,691,000 | 35,545,000 | 37,575,000 | 33,263,000 | 37,901,000 | 49,252,000 | 31,621,000 | 28,536,000 | 32,300,000 | 36,460,000 | 32,628,000 | 19,526,000 | 31,336,000 | 28,628,000 | 25,926,000 | 22,717,000 | 22,384,000 | 30,547,000 | 26,470,000 | ||||||||||||||||||||||||||||||||
income from discontinued operations, net of income taxes | 1,529,000 | -23,000 | -23,000 | -39,000 | -71,000 | -4,000 | -48,000 | 342,000 | 12,000 | -26,000 | -902,000 | -34,000 | -7,000 | -7,000 | -864,000 | 52,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
basic: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
continuing operations attributable to common shareholders | 1,640 | 1,490 | 900 | 1,140 | 1,260 | 1,250 | 1,080 | 1,100 | -630 | 1,110 | 1,140 | 980 | 940 | 790 | 750 | 800 | 710 | 810 | 1,040 | 670 | 610 | 700 | 760 | 690 | 410 | 650 | 580 | |||||||||||||||||||||||||||||||||||||
discontinued operations | 30 | 10 | -20 | -10 | -10 | -10 | -20 | -10 | -730 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
diluted: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
amortization of other intangible assets | 6,853,000 | 4,340,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from discontinued operations, net of taxes | -644,000 | -270,000 | -82,000 | -113,000 | -915,000 | -155,000 | -15,750 | -182,000 | 42,000 | 77,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
net sales related to products | 111,485,000 | 116,732,000 | 121,858,000 | 126,287,000 | 111,409,000 | 111,196,000 | 119,125,000 | 126,214,000 | 111,008,000 | 105,477,000 | 92,886,000 | 96,593,000 | 95,314,000 | 85,372,000 | 95,721,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
net sales related to services | 177,743,000 | 175,397,000 | 171,075,000 | 164,951,000 | 168,731,000 | 167,490,000 | 165,598,000 | 159,767,000 | 196,427,000 | 185,722,000 | 171,774,000 | 171,266,000 | 188,455,000 | 188,566,000 | 187,692,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
net sales | 289,228,000 | 292,129,000 | 292,933,000 | 291,238,000 | 280,140,000 | 278,686,000 | 284,723,000 | 285,981,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
amortization of other intangibles | 4,914,000 | 4,180,000 | 4,463,000 | 4,249,000 | 4,632,000 | 4,530,000 | 4,411,000 | 4,495,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other | 967,000 | 1,068,000 | -684,000 | -892,000 | -1,346,000 | -344,000 | 149,000 | 45,000 | 238,000 | -493,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income attributable to common shareowners | 25,578,000 | 18,416,000 | 21,972,000 | 30,468,000 | 26,439,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
continuing operations attributable to common shareowners | 540 | 480 | 470 | 630 | 550 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total net sales | 307,435,000 | 291,199,000 | 264,660,000 | 267,859,000 | 283,769,000 | 273,938,000 | 283,413,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
amortization of intangibles | 8,139,000 | 7,855,000 | 9,430,000 | 9,377,000 | 11,189,000 | 14,321,000 | 14,318,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income before income taxes and minority interests | 53,061,000 | 52,791,000 | 48,062,000 | 43,305,000 | 45,199,000 | 44,742,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income before minority interests | 37,960,000 | 37,481,000 | 32,573,000 | 33,435,000 | 32,611,000 | 32,282,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
minority interests | -440,000 | -538,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from continuing operations | 37,841,000 | 37,227,000 | 32,133,000 | 32,781,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from operations of discontinued businesses, net of taxes | 115,000 | -48,739,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic earnings per common share: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
continuing operations | 570 | 560 | 480 | 460 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
diluted earnings per common share: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(loss) from discontinued businesses, net of tax | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
goodwill impairment charge | 129,187,000 |
We provide you with 20 years income statements for Charles River Laboratories International stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Charles River Laboratories International stock. Explore the full financial landscape of Charles River Laboratories International stock with our expertly curated income statements.
The information provided in this report about Charles River Laboratories International stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.